Covered recipient · General Payments record
NORA A PHILLIPS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,248.75
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $395.53 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $195.40 | 10 |
| Novo Nordisk AS | $64.30 | 3 |
| Lilly USA, LLC | $48.36 | 2 |
| Galderma Laboratories, L.P. | $29.52 | 1 |
| PFIZER INC. | $20.41 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.00 | 1 |
| REVANCE THERAPEUTICS, INC. | $17.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.81 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847867 | CMS |
| ABBVIE INC. | $3.06 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847869 | CMS |
| ABBVIE INC. | $11.26 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847871 | CMS |
| ABBVIE INC. | $70.33 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847873 | CMS |
| ABBVIE INC. | $16.63 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847875 | CMS |
| ABBVIE INC. | $10.47 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847877 | CMS |
| ABBVIE INC. | $10.91 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847879 | CMS |
| ABBVIE INC. | $13.56 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847881 | CMS |
| ABBVIE INC. | $6.78 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847883 | CMS |
| ABBVIE INC. | $30.59 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107847885 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.00 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086319232 | CMS |
| Galderma Laboratories, L.P. | $29.52 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145383826 | CMS |
| Lilly USA, LLC | $22.57 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135908549 | CMS |
| Lilly USA, LLC | $25.79 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135915109 | CMS |
| Novo Nordisk Inc | $19.96 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100624816 | CMS |
| Novo Nordisk Inc | $22.48 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100326590 | CMS |
| Novo Nordisk Inc | $21.86 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100407062 | CMS |
| PFIZER INC. | $20.41 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132004722 | CMS |
| REVANCE THERAPEUTICS, INC. | $17.54 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147948540 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.